ID   GUC1A_HUMAN             Reviewed;         201 AA.
AC   P43080; B3KWT4; Q7Z6T1; Q9NU14;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 173.
DE   RecName: Full=Guanylyl cyclase-activating protein 1;
DE            Short=GCAP 1;
DE   AltName: Full=Guanylate cyclase activator 1A;
GN   Name=GUCA1A; Synonyms=C6orf131, GCAP, GCAP1, GUCA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Retina;
RX   PubMed=7983048;
RA   Subbaraya I., Ruiz C.C., Helekar B.S., Zhao X., Gorczyca W.A.,
RA   Pettenati M.J., Rao P.N., Palczewski K., Baehr W.;
RT   "Molecular characterization of human and mouse photoreceptor guanylate
RT   cyclase-activating protein (GCAP) and chromosomal localization of the
RT   human gene.";
RL   J. Biol. Chem. 269:31080-31089(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANT COD3 CYS-99.
RX   PubMed=9425234; DOI=10.1093/hmg/7.2.273;
RA   Payne A.M., Downes S.M., Bessant D.A.R., Taylor R., Holder G.E.,
RA   Warren M.J., Bird A.C., Bhattacharya S.S.;
RT   "A mutation in guanylate cyclase activator 1A (GUCA1A) in an autosomal
RT   dominant cone dystrophy pedigree mapping to a new locus on chromosome
RT   6p21.1.";
RL   Hum. Mol. Genet. 7:273-277(1998).
RN   [7]
RP   CHARACTERIZATION OF VARIANTS COD3 LEU-50 AND CYS-99.
RX   PubMed=11108966; DOI=10.1016/S0167-4889(00)00099-9;
RA   Sokal I., Li N., Verlinde C.L.M.J., Haeseleer F., Baehr W.,
RA   Palczewski K.;
RT   "Ca(2+)-binding proteins in the retina: from discovery to etiology of
RT   human disease.";
RL   Biochim. Biophys. Acta 1498:233-251(2000).
RN   [8]
RP   VARIANTS COD3 LEU-50 AND CYS-99.
RX   PubMed=11146732;
RA   Downes S.M., Holder G.E., Fitzke F.W., Payne A.M., Warren M.J.,
RA   Bhattacharya S.S., Bird A.C.;
RT   "Autosomal dominant cone and cone-rod dystrophy with mutations in the
RT   guanylate cyclase activator 1A gene-encoding guanylate cyclase
RT   activating protein-1.";
RL   Arch. Ophthalmol. 119:96-105(2001).
RN   [9]
RP   VARIANT COD3 GLY-155.
RX   PubMed=11484154; DOI=10.1086/323265;
RA   Wilkie S.E., Li Y., Deery E.C., Newbold R.J., Garibaldi D.,
RA   Bateman J.B., Zhang H., Lin W., Zack D.J., Bhattacharya S.S.,
RA   Warren M.J., Hunt D.M., Zhang K.;
RT   "Identification and functional consequences of a new mutation (E155G)
RT   in the gene for GCAP1 that causes autosomal dominant cone dystrophy.";
RL   Am. J. Hum. Genet. 69:471-480(2001).
RN   [10]
RP   VARIANT COD3 ILE-143 DELINS ASN-THR, AND VARIANT ILE-114.
RX   PubMed=15505030; DOI=10.1167/iovs.04-0590;
RA   Nishiguchi K.M., Sokal I., Yang L., Roychowdhury N., Palczewski K.,
RA   Berson E.L., Dryja T.P., Baehr W.;
RT   "A novel mutation (I143NT) in guanylate cyclase-activating protein 1
RT   (GCAP1) associated with autosomal dominant cone degeneration.";
RL   Invest. Ophthalmol. Vis. Sci. 45:3863-3870(2004).
RN   [11]
RP   VARIANT COD3 PHE-151.
RX   PubMed=15790869; DOI=10.1167/iovs.04-1431;
RA   Sokal I., Dupps W.J., Grassi M.A., Brown J. Jr., Affatigato L.M.,
RA   Roychowdhury N., Yang L., Filipek S., Palczewski K., Stone E.M.,
RA   Baehr W.;
RT   "A novel GCAP1 missense mutation (L151F) in a large family with
RT   autosomal dominant cone-rod dystrophy (adCORD).";
RL   Invest. Ophthalmol. Vis. Sci. 46:1124-1132(2005).
RN   [12]
RP   VARIANT COD3 PHE-151.
RX   PubMed=15735604;
RA   Jiang L., Katz B.J., Yang Z., Zhao Y., Faulkner N., Hu J., Baird J.,
RA   Baehr W., Creel D.J., Zhang K.;
RT   "Autosomal dominant cone dystrophy caused by a novel mutation in the
RT   GCAP1 gene (GUCA1A).";
RL   Mol. Vis. 11:143-151(2005).
RN   [13]
RP   VARIANTS COD3 LYS-89; GLU-100; PHE-151 AND VAL-159, CHARACTERIZATION
RP   OF VARIANTS COD3 LYS-89; GLU-100 AND VAL-159, AND FUNCTION.
RX   PubMed=19459154; DOI=10.1002/humu.21055;
RA   Kitiratschky V.B.D., Behnen P., Kellner U., Heckenlively J.R.,
RA   Zrenner E., Jaegle H., Kohl S., Wissinger B., Koch K.-W.;
RT   "Mutations in the GUCA1A gene involved in hereditary cone dystrophies
RT   impair calcium-mediated regulation of guanylate cyclase.";
RL   Hum. Mutat. 30:E782-E796(2009).
CC   -!- FUNCTION: Stimulates retinal guanylyl cyclase when free calcium
CC       ions concentration is low and inhibits guanylyl cyclase when free
CC       calcium ions concentration is elevated (PubMed:19459154). This
CC       Ca(2+)-sensitive regulation of retinal guanylyl cyclase is a key
CC       event in recovery of the dark state of rod photoreceptors
CC       following light exposure. {ECO:0000269|PubMed:19459154,
CC       ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Lipid-anchor.
CC   -!- TISSUE SPECIFICITY: Retina; cone outer and inner segments, in
CC       particular, in disk membrane regions, and to a lesser extent rod
CC       inner and outer segments.
CC   -!- DOMAIN: Binds three calcium ions (via EF-hands 2, 3 and 4) when
CC       calcium levels are high. Binds Mg(2+) when calcium levels are low.
CC       {ECO:0000250|UniProtKB:P46065}.
CC   -!- DISEASE: Cone dystrophy 3 (COD3) [MIM:602093]: An autosomal
CC       dominant cone dystrophy. Cone dystrophies are retinal dystrophies
CC       characterized by progressive degeneration of the cone
CC       photoreceptors with preservation of rod function, as indicated by
CC       electroretinogram. However, some rod involvement may be present in
CC       some cone dystrophies, particularly at late stage. Affected
CC       individuals suffer from photophobia, loss of visual acuity, color
CC       vision and central visual field. Another sign is the absence of
CC       macular lesions for many years. Cone dystrophies are distinguished
CC       from the cone-rod dystrophies in which some loss of peripheral
CC       vision also occurs. {ECO:0000269|PubMed:11108966,
CC       ECO:0000269|PubMed:11146732, ECO:0000269|PubMed:11484154,
CC       ECO:0000269|PubMed:15505030, ECO:0000269|PubMed:15735604,
CC       ECO:0000269|PubMed:15790869, ECO:0000269|PubMed:19459154,
CC       ECO:0000269|PubMed:9425234}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD92530.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Mutations of the GUCA1A gene; Note=Retina
CC       International's Scientific Newsletter;
CC       URL="http://www.retina-international.org/files/sci-news/gcmut.htm";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L36859; AAA60541.1; -; mRNA.
DR   EMBL; L36861; AAA60542.1; -; Genomic_DNA.
DR   EMBL; AK125780; BAG54246.1; -; mRNA.
DR   EMBL; AL096814; CAB89167.1; -; Genomic_DNA.
DR   EMBL; AL096814; CAD92530.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471081; EAX04084.1; -; Genomic_DNA.
DR   EMBL; BC031663; AAH31663.1; -; mRNA.
DR   CCDS; CCDS4864.1; -.
DR   PIR; C55331; C55331.
DR   RefSeq; NP_000400.2; NM_000409.4.
DR   RefSeq; NP_001305990.1; NM_001319061.1.
DR   RefSeq; NP_001305991.1; NM_001319062.1.
DR   RefSeq; XP_011512839.1; XM_011514537.2.
DR   RefSeq; XP_011512841.1; XM_011514539.1.
DR   UniGene; Hs.92858; -.
DR   ProteinModelPortal; P43080; -.
DR   SMR; P43080; -.
DR   BioGrid; 109233; 1.
DR   IntAct; P43080; 4.
DR   STRING; 9606.ENSP00000053469; -.
DR   DrugBank; DB08231; MYRISTIC ACID.
DR   BioMuta; GUCA1A; -.
DR   DMDM; 46577585; -.
DR   PaxDb; P43080; -.
DR   PeptideAtlas; P43080; -.
DR   PRIDE; P43080; -.
DR   DNASU; 2978; -.
DR   Ensembl; ENST00000053469; ENSP00000053469; ENSG00000048545.
DR   Ensembl; ENST00000372958; ENSP00000362049; ENSG00000048545.
DR   Ensembl; ENST00000394237; ENSP00000377784; ENSG00000048545.
DR   GeneID; 2978; -.
DR   KEGG; hsa:2978; -.
DR   UCSC; uc003orx.4; human.
DR   CTD; 2978; -.
DR   DisGeNET; 2978; -.
DR   GeneCards; GUCA1A; -.
DR   HGNC; HGNC:4678; GUCA1A.
DR   HPA; HPA005561; -.
DR   MalaCards; GUCA1A; -.
DR   MIM; 600364; gene.
DR   MIM; 602093; phenotype.
DR   neXtProt; NX_P43080; -.
DR   OpenTargets; ENSG00000048545; -.
DR   Orphanet; 1872; Cone rod dystrophy.
DR   Orphanet; 1871; Progressive cone dystrophy.
DR   PharmGKB; PA29062; -.
DR   eggNOG; KOG0044; Eukaryota.
DR   eggNOG; COG5126; LUCA.
DR   GeneTree; ENSGT00760000118820; -.
DR   HOGENOM; HOG000233019; -.
DR   HOVERGEN; HBG108179; -.
DR   InParanoid; P43080; -.
DR   KO; K08328; -.
DR   PhylomeDB; P43080; -.
DR   TreeFam; TF333971; -.
DR   Reactome; R-HSA-2514859; Inactivation, recovery and regulation of the phototransduction cascade.
DR   GeneWiki; GUCA1A; -.
DR   GenomeRNAi; 2978; -.
DR   PRO; PR:P43080; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000048545; -.
DR   CleanEx; HS_GUCA1A; -.
DR   ExpressionAtlas; P43080; baseline and differential.
DR   Genevisible; P43080; HS.
DR   GO; GO:0097381; C:photoreceptor disc membrane; TAS:Reactome.
DR   GO; GO:0001917; C:photoreceptor inner segment; IEA:Ensembl.
DR   GO; GO:0005509; F:calcium ion binding; ISS:UniProtKB.
DR   GO; GO:0008048; F:calcium sensitive guanylate cyclase activator activity; ISS:UniProtKB.
DR   GO; GO:0030249; F:guanylate cyclase regulator activity; ISS:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0007602; P:phototransduction; IEA:Ensembl.
DR   GO; GO:0031284; P:positive regulation of guanylate cyclase activity; ISS:UniProtKB.
DR   GO; GO:0022400; P:regulation of rhodopsin mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; NAS:ProtInc.
DR   GO; GO:0007601; P:visual perception; TAS:ProtInc.
DR   CDD; cd00051; EFh; 2.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR033022; GUCA1A.
DR   PANTHER; PTHR23055:SF113; PTHR23055:SF113; 1.
DR   Pfam; PF00036; EF-hand_1; 1.
DR   Pfam; PF13499; EF-hand_7; 1.
DR   SMART; SM00054; EFh; 3.
DR   SUPFAM; SSF47473; SSF47473; 1.
DR   PROSITE; PS00018; EF_HAND_1; 3.
DR   PROSITE; PS50222; EF_HAND_2; 4.
PE   1: Evidence at protein level;
KW   Calcium; Complete proteome; Disease mutation; Lipoprotein; Membrane;
KW   Metal-binding; Myristate; Reference proteome; Repeat;
KW   Sensory transduction; Vision.
FT   INIT_MET      1      1       Removed. {ECO:0000255}.
FT   CHAIN         2    201       Guanylyl cyclase-activating protein 1.
FT                                /FTId=PRO_0000073803.
FT   DOMAIN       14     49       EF-hand 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN       51     86       EF-hand 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN       87    122       EF-hand 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   DOMAIN      131    166       EF-hand 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND      64     75       1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     100    111       2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   CA_BIND     144    155       3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00448}.
FT   MOD_RES       3      3       Deamidated asparagine. {ECO:0000255}.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000250|UniProtKB:P46065}.
FT   VARIANT      50     50       P -> L (in COD3; some subjects may
FT                                present a moderately severe cone-rod
FT                                dystrophy; causes a decrease in the
FT                                number of bound calcium ions from 3 to 2,
FT                                without changing the activity profile;
FT                                dbSNP:rs104893968).
FT                                {ECO:0000269|PubMed:11108966,
FT                                ECO:0000269|PubMed:11146732}.
FT                                /FTId=VAR_010648.
FT   VARIANT      89     89       E -> K (in COD3; exhibits an about 6-fold
FT                                shift of ionic calcium concentration at
FT                                which the guanylate cyclase activity is
FT                                halfmaximal).
FT                                {ECO:0000269|PubMed:19459154}.
FT                                /FTId=VAR_060802.
FT   VARIANT      99     99       Y -> C (in COD3; type 1A; alters calcium
FT                                ion sensitivity, leading to the
FT                                constitutive stimulating activity of GC1
FT                                at high calcium ion concentration, where
FT                                normal GUCA1A inhibits it;
FT                                dbSNP:rs104893967).
FT                                {ECO:0000269|PubMed:11108966,
FT                                ECO:0000269|PubMed:11146732,
FT                                ECO:0000269|PubMed:9425234}.
FT                                /FTId=VAR_001372.
FT   VARIANT     100    100       D -> E (in COD3; exhibits an about 28-
FT                                fold shift of ionic calcium concentration
FT                                at which the guanylate cyclase activity
FT                                is halfmaximal).
FT                                {ECO:0000269|PubMed:19459154}.
FT                                /FTId=VAR_060803.
FT   VARIANT     114    114       T -> I (in a patient with an atypical
FT                                form of retinitis pigmentosa; unknown
FT                                pathological significance;
FT                                dbSNP:rs771261841).
FT                                {ECO:0000269|PubMed:15505030}.
FT                                /FTId=VAR_060804.
FT   VARIANT     143    143       I -> NT (in COD3).
FT                                {ECO:0000269|PubMed:15505030}.
FT                                /FTId=VAR_060805.
FT   VARIANT     151    151       L -> F (in COD3; dbSNP:rs121434631).
FT                                {ECO:0000269|PubMed:15735604,
FT                                ECO:0000269|PubMed:15790869,
FT                                ECO:0000269|PubMed:19459154}.
FT                                /FTId=VAR_060806.
FT   VARIANT     155    155       E -> G (in COD3; constitutive activation
FT                                of GC1). {ECO:0000269|PubMed:11484154}.
FT                                /FTId=VAR_012987.
FT   VARIANT     159    159       G -> V (in COD3; exhibits an about 18-
FT                                fold shift of ionic calcium concentration
FT                                at which the guanylate cyclase activity
FT                                is halfmaximal).
FT                                {ECO:0000269|PubMed:19459154}.
FT                                /FTId=VAR_060807.
FT   CONFLICT     79     79       A -> G (in Ref. 1; AAA60541/AAA60542).
FT                                {ECO:0000305}.
SQ   SEQUENCE   201 AA;  22920 MW;  063C6AD61BE44406 CRC64;
     MGNVMEGKSV EELSSTECHQ WYKKFMTECP SGQLTLYEFR QFFGLKNLSP SASQYVEQMF
     ETFDFNKDGY IDFMEYVAAL SLVLKGKVEQ KLRWYFKLYD VDGNGCIDRD ELLTIIQAIR
     AINPCSDTTM TAEEFTDTVF SKIDVNGDGE LSLEEFIEGV QKDQMLLDTL TRSLDLTRIV
     RRLQNGEQDE EGADEAAEAA G
//
